The Office for Civil Rights (OCR) at HHS announced on December 10 proposed modifications to the HIPAA Privacy Rule, placing an emphasis on individuals’ right of access to their protected health information (PHI).
CMS recently released two new HCPCS Level II codes for Regeneron’s antibody drugs casirivimab and imdevimab, effective for dates of service on or after November 21. The creation of the new codes comes in response to the Food and Drug Administration issuance of an emergency use authorization for the drug therapies on November 9.
Q: How does CMS define a "shoppable service"? What information needs to be included in the list of 300 shoppable services required by the Hospital Price Transparency final rule?
Q: We have an elderly patient admitted to our hospital who is also presenting with osteoarthritis (OA) of the right knee. How can we determine primary versus secondary OA, and how would it be reported in ICD-10-CM?
Q: When dealing with a natural disaster such as the California wildfires, does the HIPAA Privacy Rule allow information to be shared more easily? What are some examples of changes to the Privacy Rule during these circumstances?
Q: Many people are experiencing prolonged isolation during the novel coronavirus (COVID-19) pandemic. How is this affecting their health outcomes, and how can case managers help?
CMS recently published FAQs and other resources to help organizations correctly bill for services that are subject to the three-day payment window policy.
Tufts Health Plan, a Massachusetts-based health insurance company, reported a breach on November 25 that affected 60,545 individuals, according to the Office for Civil Rights (OCR) breach report.
The Centers for Disease Control and Prevention (CDC) December 3 announced the implementation of six new ICD-10-CM codes to identify conditions related to COVID-19.
